Inovio Pharmaceuticals (INO) DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
5/14/2013 9:52:20 AM
More...
|
Inovio Pharmaceuticals (INO) Reports 2013 First Quarter Financial Results
5/13/2013 6:21:02 AM
More...
|
Inovio Pharmaceuticals (INO) Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
4/19/2013 8:49:38 AM
More...
|
Inovio Pharmaceuticals (INO) Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
4/18/2013 10:40:36 AM
More...
|
Inovio Pharmaceuticals (INO) and US Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
4/10/2013 10:08:29 AM
More...
|
Inovio Pharmaceuticals (INO) Collaborator ChronTech Reports Interim Phase II Clinical Study Results From ChronVac-C Vaccine for Hepatitis C Infection
4/2/2013 9:22:21 AM
More...
|
Inovio Pharmaceuticals (INO) to Present at BioCentury's "Future Leaders in the Biotech Industry" Conference
3/28/2013 6:46:12 AM
More...
|
Inovio Pharmaceuticals (INO) Reports 2012 Fourth Quarter and Year End Financial Results
3/19/2013 7:02:56 AM
More...
|
Inovio Pharmaceuticals (INO) Closes $15.1 Million Offering of Common Stock and Warrants
3/13/2013 9:21:52 AM
More...
|
Inovio Pharmaceuticals (INO) Prices $15.1 Million Offering of Common Stock and Warrants
3/7/2013 10:12:54 AM
More...
|
|